Xoma Fails Phase 3 Trial For Rare Eye Disease
July 22, 2015 at 20:29 PM EDT
Xoma shares closed the day down 77% after failing a phase 3 trial for Behcets-disease Uveitis.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |